https://www.selleckchem.com/pr....oducts/sacituzumab-g
1 was characterized by immunosuppression with higher mortality rate than class 2. We further developed a 5-gene class model to predict class membership. The study was funded by the National Natural Science Foundation of China (Grant No. 81,901,929). The study was funded by the National Natural Science Foundation of China (Grant No. 81,901,929). High rates of recurrence after resection severely worsen hepatocellular carcinoma (HCC) prognosis. This study aims to explore whether circulating tumor cell (CTC) is helpful in dete
Respect!
Kommentar
Delen
